Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist
Debated Unsettled Safety Issues Cancer Concerns about a possible connection between GLP-1 RAs and the development of neoplasms have spurred several investigations, especially on thyroid and pancreatic cancers due to a plausible mechanism and a large number of reports in the post-marketing phase [118, 128, 130]
this is the default for ACA/Exchange CareFirst members, who face an explicit exclusion List price with no coverage before any manufacturer savings card
That is a meaningful preclinical signal but it is a single research groups model, in one species, without the independent multi-lab replication that would be needed before any human inference
While it is a unique medication, it shares some similarities with other treatments in its class
Although the current studies on KD and PD show some promising results, there are fewer intervention studies in PD populations, relatively short treatment durations in those with small sample sizes, and the lack of PD-specific outcomes that do exist
